The wholly-owned subsidiary ShanDong Guobang received the on-site inspection report issued by the USA FDA, which indicates that the ShanDong Guobang factory located at No. 02131, Jiangxi Street has passed this cGMP on-site inspection. The inspection covers the production and manufacturing of Active Pharmaceutical Ingredient (florfenicol), including six major systems: quality system, materials, production, packaging and labeling, equipment facilities, and laboratory control.
国邦医药：子公司产品氟苯尼考通过美国FDA现场检查
Guobang Pharmaceutical: Subsidiary's product florfenicol passes the USA FDA on-site inspection.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated